Gemcitabine-associated thrombotic thrombocytopenic purpura.
about
Disseminated carcinoma diagnosed by bone marrow biopsy in patients with microangiopathic hemolytic anemia and thrombocytopenia: a report of two cases with gastric cancer and a review of the literature.Thrombotic thrombocytopenic purpura and gemcitabine.Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series.Gemcitabine-induced thrombotic microangiopathy.Thrombotic thrombocytopenic purpura following salvage chemotherapy with paclitaxel, ifosfamide and cisplatin in a patient with a refractory germ cell tumor: A case report and review of the literatureA case of gemcitabine-induced thrombotic microangiopathy in a urothelial tumor patient with a single kidney.Rituximab to treat gemcitabine-induced hemolytic-uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review.Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Nephrotoxicity of recent anti-cancer agents.Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis.Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin in development for the treatment of prostate cancer.Use of eculizumab in refractory gemcitabine-induced thrombotic microangiopathy.Thrombotic microangiopathy associated with gemcitabine: rare but real.ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.Delayed Development of Hemolytic Anemia with Fragmented Red Blood Cells and Cardiac and Renal Impairments after High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Malignant Lymphoma.TTP-HUS associated with sunitinib.tHe USual Suspects.Gemcitabine-induced haemolytic uremic syndrome, although infrequent, can it be prevented: A case report and review of literature
P2860
Q33391765-0DDE7AA7-B5C7-46DB-8BE2-C3945BB3C672Q33395859-934B6B3A-6FB9-4005-B1E2-AEED83594654Q33410709-5BA2626A-1F45-455E-9A22-3FCC2167E3A5Q33411493-B039ACB0-9273-453B-92B6-AF2F1E05A920Q33428025-4EA5988F-AC39-4E0D-86AC-282E2403E873Q33429292-FBB2C6C6-C407-4607-90CC-D85C274DAB38Q33434397-47B3A081-BCE7-4AA4-BD28-F688C07E42C9Q33441161-BE0533BA-AF53-4D65-8F70-63B2F28EE995Q34122035-A7BA37CA-84FA-4CB4-BAB9-3265D0B03985Q35310741-F3FCC18E-96A2-4C1C-977D-FF8B1670571CQ37161885-5024DCF0-7021-4F33-8877-C41C5C117C4DQ39524455-1B86BFDA-6B40-4C2C-93CF-8F740424AC03Q44441605-3CAD3147-A0AD-4DEA-9B71-C3E885F4B28EQ45978337-97CE5EB6-0252-4935-9A11-DD533B307E99Q47630342-1538F3B6-804D-4892-B6C9-EDB4F04D6B1AQ50195063-07B4BCB0-0A1C-44F7-899B-3DC782067375Q50321712-3A3C0FC2-014C-43D2-9245-A6D8D0030ADAQ54356064-CEB7E395-778A-4DBD-91B2-FCE44387A056Q58551524-769DF079-B3A3-480A-9B7E-BC59FB1D0123
P2860
Gemcitabine-associated thrombotic thrombocytopenic purpura.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Gemcitabine-associated thrombotic thrombocytopenic purpura.
@ast
Gemcitabine-associated thrombotic thrombocytopenic purpura.
@en
type
label
Gemcitabine-associated thrombotic thrombocytopenic purpura.
@ast
Gemcitabine-associated thrombotic thrombocytopenic purpura.
@en
prefLabel
Gemcitabine-associated thrombotic thrombocytopenic purpura.
@ast
Gemcitabine-associated thrombotic thrombocytopenic purpura.
@en
P2093
P1433
P1476
Gemcitabine-associated thrombotic thrombocytopenic purpura.
@en
P2093
Farheen Shah-Khan
Melanie Zupancic
Prabodh C Shah
P304
P356
10.1016/S1470-2045(07)70203-6
P577
2007-07-01T00:00:00Z